Medicare projects stable average prescription drug premiums in 2017
Centers for Medicare & Medicaid Services | Jul 29, 2016
Centers for Medicare & Medicaid Services | Jul 25, 2016 | Arizona
As part of our efforts to increase the transparency of federal health programs, the Centers for Medicare & Medicaid Services (CMS) today released a public data set that provides information on services provided to Medicare beneficiaries by skilled nursing facilities (SNFs). The Skilled Nursing Facility Utilization and Payment Public Use
Today, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to test new models to improve how Medicare Part B pays for prescription drugs and supports physicians and other clinicians in delivering higher quality care. CMS values public input and comments as part of the rulemaking process,
First set of core measures, used as basis for quality-based payments, were developed by new broad collaborative of health care system participants. Today, the Centers for Medicare & Medicaid Services (CMS) and America’s Health Insurance Plans (AHIP), as part of a broad Core Quality Measures Collaborative of health care system
The Centers for Medicare & Medicaid Services (CMS) today proposed rules that will expand access to analyses and data that will help providers, employers, and others make more informed decisions about care delivery. The new rules, as required by the Medicare Access and CHIP Reauthorization Act (MACRA), will allow organizations
The Department of Health and Human Services today announced a new funding opportunity of up to $157 million to test whether screening beneficiaries for health-related social needs and associated referrals to and navigation of community-based services will improve quality and affordability in Medicare and Medicaid. The five-year program, called the
On December 11, 2015, the Department of Health and Human Services (HHS) and the Department of the Treasury posted guidance in the Federal Register for states interested in seeking a State Innovation Waiver under section 1332 of the Affordable Care Act. The guidance provides states with flexibility to pursue innovative